glutathione mat2a

glutathione mat2a enhances PARN transcription via SRF to accelerate glycolysis and drive malignant progression in osteosarcoma Frontiers | The potential and

Name: glutathione mat2a enhances PARN transcription via SRF to accelerate glycolysis and drive malignant progression in osteosarcoma Frontiers | The potential and
Brand: condeoeiras.edu.pt
SKU: 15400697091
Price: 27.43 USD
Availability: InStock
Rating: 4.8388 (18 reviews)

Frontiers The potential and challenges of targeting MTAP negative cancers beyond synthetic lethality The nuclear role of methionine adenosyltransferase 2A in immunoglobulin class switch recombination bioRxiv Translocation of Methionine Adenosyl Transferase MAT2A and Its Prognostic Relevance for Liver Hepatocellular Carcinoma Cardiac Energy Dependence on Glucose Increases Metabolites Related to Glutathione and Activates Metabolic Genes Controlled by Mechanistic Target of Rapamycin Journal of the American Heart Association Reciprocal links between methionine metabolism, DNA repair and therapy resistance in glioblastoma bioRxiv Emerging roles for methionine metabolism in immune cell fate and function PMC

SKU: 15400697091 · From condeoeiras.edu.pt

4.8

USD27.43 USD57.43

Pay in 4 interest-free payments of $6.86 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 2 - Aug 7

Description

Sorenson WR, Sullivan D

The reduced O 2 synthesis in the Q sites of cyt c can be achieved pharmacologically by inhibiting the Qo and Qi sites with antimycin A [133] and myxothiazol [134], e.g., in rat hippocampal CA1 cells, with stigmatellin, e.g., in cremaster arterioles of wild type mice [135], and with Ginsenoside Rc, e.g., in rat cardiomyocytes after ischemia/reperfusion [136]

3729-C EMPOWERING THE FRONTLINE: ENHANCING HEPATITIS C TREATMENT ACCESSIBILITY IN PRIMARY CARE THROUGH PROCESS DESIGN AND RESIDENT EDUCATION Rita Auro, Michael Schwartz and Alexandra Lane, Cooper University Health Care Background: In 2022, the World Health Organization (WHO) recommended simplifying the hepatitis C virus (HCV) care pathway to improve treatment access, advocating for diagnosis and management in primary care (PC) settings